CHEMILUMINESCENCE IMAGING MARKET ANALYSIS

Chemiluminescence Imaging Market, by Application Type (Chemiluminescence Immunoassay, DNA Hybridization, Western Blotting, Southern Blotting, Hormones (Insulin, Thyroxin, Estradiol), Vitamin (Vit 12), Forensic Sciences, Southern Blotting ,Tumor Marker, and Others), by End User (Diagnostics Laboratory, Research and Academic Institutes, Forensic Laboratories, and Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Sep 2024
Code : CMI2497
Formats :
Excel and PDF
Industry : Medical Imaging

Market News

Key Development

In August 2017, Azure Biosystems Inc., launched Sapphire Biomolecular Imager, a next generation laser scanner system that offers fluorescent imaging in the Near IR (NIR) and Visible Wavelengths (RGB), true chemiluminescent imaging.

In September 2017, DiaSorin S.p.A., acquired ELISA technology business from Siemens. The objective of acquisition was to convert the current client base that uses ELISA tests towards CLIA technology solutions.

CHEMILUMINESCENCE IMAGING MARKET ANALYSIS

Market News

Chemiluminescence Imaging Market Report Snapshots

EXISTING CLIENTELE